Evaluation of Magnetic Fluid Hyperthermia in a Standard Rat Model of Prostate Cancer
- 1 June 2004
- journal article
- research article
- Published by Mary Ann Liebert Inc in Journal of Endourology
- Vol. 18 (5) , 495-500
- https://doi.org/10.1089/0892779041271715
Abstract
Purpose : To examine the feasibility and potential of magnetic fluid hyperthermia (MFH) as a minimally invasive method for hyperthermia treatment of prostate cancer. Materials and Methods : Orthotopic Dunning R3327 prostate tumors were induced in 20 male Copenhagen rats. The animals either received MFH treatment following intratumoral administration of magnetic fluids or were used as either tumor growth controls for determination of iron distribution in selected organs or as histologic controls without MFH treatment. The MFH treatments were carried out at 45°C or 50°C using an AC magnetic field applicator system designed for small animals. Results : Sequential treatments with MFH were possible following a single intratumoral injection of magnetic fluid. Intratumoral temperatures of 50°C and more were obtained and were monitored online using fluoro-optic thermometry. Four days after MFH treatments, 79% of the injected dose of ferrites was still present in the prostate. Conclusions : The successful intraprostatic nanoparticle infiltration and stable steady-state intratumoral treatment temperatures demonstrate the feasibility of MFH in a prostate cancer model. Efficacy and survival benefit must be confirmed in further experiments.Keywords
This publication has 13 references indexed in Scilit:
- The new synthetic matrix metalloproteinase inhibitor (Roche 28-2653) reduces tumor growth and prolongs survival in a prostate cancer standard rat modelOncogene, 2002
- Presentation of a new magnetic field therapy system for the treatment of human solid tumors with magnetic fluid hyperthermiaJournal of Magnetism and Magnetic Materials, 2001
- Synthetic inhibitor of matrix metalloproteinases (batimastat) reduces prostate cancer growth in an orthotopic rat modelThe Prostate, 2000
- Magnetic fluid hyperthermia (MFH): Cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticlesJournal of Magnetism and Magnetic Materials, 1999
- Endocytosis of dextran and silan-coated magnetite nanoparticles and the effect of intracellular hyperthermia on human mammary carcinoma cells in vitroJournal of Magnetism and Magnetic Materials, 1999
- Workgroup I: Rodent models of prostate cancerThe Prostate, 1998
- Effects of Magnetic Fluid Hyperthermia (MFH) on C3H mammary carcinomain vivoInternational Journal of Hyperthermia, 1997
- Cellular uptake of magnetic fluid particles and their effects on human adenocarcinoma cells exposed to AC magnetic fieldsin vitroInternational Journal of Hyperthermia, 1996
- Inductive heating of ferrimagnetic particles and magnetic fluids: Physical evaluation of their potential for hyperthermiaInternational Journal of Hyperthermia, 1993
- The in vivo effect of regional hyperthermia on dunning R3327 prostatic tumorThe Prostate, 1991